Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
blood test
MedTech
Grail stock craters as Galleri trial fails to hit endpoint
Grail’s shares plummeted more than 45% after-hours Thursday as the medtech revealed a major trial of its Galleri test missed its primary endpoint.
Ben Adams
Feb 20, 2026 7:30am
Study finds blood test can predict age of Alzheimer's onset
Feb 19, 2026 7:20am
Hims & Hers to sell Grail’s Galleri multi-cancer blood test
Feb 4, 2026 10:55am
Quest launches residual disease blood test for multiple myeloma
Feb 3, 2026 6:15am
Saga Diagnostics expands blood test to include colorectal cancer
Jan 13, 2026 8:55am
Quanterix nabs Illumina’s CCO as new leader
Jan 9, 2026 10:45am
